NCT02348320
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +6 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
Clinical trial condition
Triple Negative Breast Neoplasms
Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.
39 public trials
13 recruiting studies
Triple Negative Breast Neoplasms trial results
- Conditions
- BRCA 1 /2 and / or HRD, Breast Cancer, Breast Diseases, +8 more
- Locations
-
- Kliniken Esslingen, Gynäkologie Onkologie Esslingen am Neckar, Baden-Wurttemberg, Germany
- Universitätsklinikum Erlangen Erlangen, Bavaria, Germany
- Onkologisches Zentrum am Rotkreuzklinikum München München, Bavaria, Germany
- Elisabeth Krankenhaus Kassel, Hesse, Germany
NCT03539965
- Conditions
- Breast Diseases, Breast Neoplasms, Disease Attributes, +10 more
- Locations
-
- Instituto Nacional do Cancer - CPQ Rio de Janeiro, Brazil
Active, Not Recruiting
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
NCT06157892
- Conditions
- Advanced Breast Cancer, Advanced Gastric Cancer, Breast Diseases, +17 more
- Locations
-
- Banner-University Medical Center Tucson Campus Tucson, Arizona, United States
- Banner-University Medical Center Tucson Campus Tucson, Arizona, United States
- The University of Arizona Cancer Center-North Campus Pharmacy, Attn: Kelly Myrdal Tucson, Arizona, United States
- University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
Active, Not Recruiting
A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer
NCT03742102
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- Research Site Tucson, Arizona, United States
- Research Site Columbia, Maryland, United States
- Research Site Boston, Massachusetts, United States
- Research Site Boston, Massachusetts, United States
Active, Not Recruiting
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
NCT05544929
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adenoma, +83 more
- Locations
-
- Massachusetts General Hospital . Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- NYU School of Medicine New York, United States
- University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
Active, Not Recruiting
Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC
NCT03997123
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- Research Site Whittier, California, United States
- Research Site Whittier, California, United States
- Research Site Fort Myers, Florida, United States
- Research Site Miami, Florida, United States
Active, Not Recruiting
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
NCT04561362
- Conditions
- Adnexal Diseases, Advanced Solid Tumor, Breast Diseases, +30 more
- Locations
-
- Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
- Ocala Oncology Center Ocala, Florida, United States
- Advent Health Orlando, Florida, United States
- Icahn School of Medicine at Mount Sinai New York, United States
Active, Not Recruiting
NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC
NCT04335669
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +10 more
- Locations
-
- Vejle Hospital Vejle, Region Syd, Denmark
- Aalborg Universitetshospita Aalborg, Denmark
- Rigshospitalet Copenhagen, Denmark
- Sydvestjysk Sygehus Esbjerg, Denmark